Cargando…
Use of sacubitril/valsartan in acute decompensated heart failure: a case report
Refractory heart failure typically requires costly long‐term, continuous intravenous inodilator infusions while patients await mechanical circulatory support or cardiac transplantation. The combined angiotensin receptor blocker–neprilysin inhibitor, sacubitril/valsartan, is a novel therapy that can...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5793985/ https://www.ncbi.nlm.nih.gov/pubmed/29035000 http://dx.doi.org/10.1002/ehf2.12219 |